GLAUKOS Corp (GKOS) stock
GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30219% above fair value
$245.72−0.31 (-0.13%)
Close on Nov 13, 2026Market cap $14.55BP/E –Yield –
Glaukos enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Glaukos's enterprise value was $14.43B on Nov 11, 2026, against $6.00B a year earlier. Over the last 5 years it ranged from $1.80B to $14.43B, with a median of $4.77B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $14.43B | +126.3% |
| 2025 | Dec 31, 2025 | $6.38B | -21.8% |
| 2024 | Dec 31, 2024 | $8.16B | +117.0% |
| 2023 | Dec 29, 2023 | $3.76B | +90.9% |
| 2022 | Dec 30, 2022 | $1.97B | +0.5% |
| 2021 | Dec 31, 2021 | $1.96B | -40.3% |
| 2020 | Dec 31, 2020 | $3.28B | +67.3% |
| 2019 | Dec 31, 2019 | $1.96B | -1.0% |
| 2018 | Dec 31, 2018 | $1.98B | +128.7% |
| 2017 | Dec 29, 2017 | $866.99M | -24.0% |
| 2016 | Dec 30, 2016 | $1.14B | +60.4% |
| 2015 | Dec 31, 2015 | $711.07M | – |
See a number that looks wrong?